Terkko Navigator / Acta Oncologica

Prediction of survival outcomes following postoperative radiotherapy after radical prostatectomy for prostate cancer.

Neurologic disorders in long-term survivors of neuroblastoma - a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) research program.

Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.

The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry.

Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature.

Commentary: RBE in proton therapy - where is the experimental in vivo data?

Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients.

Terminal digit preference: a source of measurement error in breast cancer diameter reporting.

Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial.

Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma.

Successful treatment of central nervous system involved Erdheim-Chester disease by intermediate-dose cytarabine as first-line therapy.

Agreement between the Danish Cancer Registry and the Danish Colorectal Cancer Group Database.

68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases of recurrent prostate cancer after initial surgery.

Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.

Regenerative nodular hyperplasia after T-DM1: consequences from sinusoidal endothelium damages.

Mounting evidence supports the safety of weight lifting after breast cancer.

The impact of smoking on the effectiveness of immune checkpoint inhibitors - a systematic review and meta-analysis.

Regional lung avoidance by CT numbers to reduce radiation-induced lung damage risk in non-small-cell lung cancer: a simulation study.

PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis.

Smoking-adjusted risk of renal pelvis cancer by occupation: a population-based cohort study of Nordic men.

L1CAM expression in colorectal cancer identifies a high-risk group of patients with dismal prognosis already in early-stage disease.

45 GyRBE for group III orbital embryonal rhabdomyosarcoma.

MRI-guided definition of cerebrospinal fluid distribution around cranial and sacral nerves: implications for brain tumors and craniospinal irradiation.

Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study.

Graded activity is an important component in cognitive behavioral therapy to reduce severe fatigue: results of a pragmatic crossover trial in cancer survivors.

A prospective, multicenter DAHANCA study of hyperfractionated, accelerated radiotherapy for head and neck squamous cell carcinoma.

Risk of brainstem necrosis in pediatric patients with central nervous system malignancies after pencil beam scanning proton therapy.

Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts.

Incidence and survival of hypopharyngeal cancer: a Danish Nation-Wide Study from 1980 to 2014.

Epithelioid sarcoma: half a century later.

Are Individual patient data meta-analyses still needed today in oncology? A discussion focused on Head and Neck oncology.

Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis.

ARAP1 is an independent prognostic biomarker in older women with ovarian high-grade serous adenocarcinoma receiving first-line platinum-based antineoplastic therapy.

Cancer registration in the era of modern oncology and GDPR.

Stereotactic body radiation therapy for early-stage hepatocellular carcinoma - a systematic review on outcome.

The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy.

Analysis of human papillomaviruses and human polyomaviruses in lung cancer from Swedish never-smokers.

Elevated neutrophil-lymphocyte ratio combined with hyponatremia indicate poor prognosis in renal cell carcinoma.

Nordic cervical screening on common ground.

Trends of colorectal cancer incidence by education and socioeconomic status in Finland.

NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy.

Radiation dose and pathological response in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgery: a multi-institutional analysis.

Dual-tracer PET of viable tumor volume and hypoxia for identification of necrosis-containing radio-resistant Sub-volumes.

Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011-2016.

The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT.

Testing the methodology for a dosimetric end-to-end audit of IMRT/VMAT: results of IAEA multicentre and national studies.

Malignant lymphoma in granulomatosis with polyangiitis: subtypes, clinical characteristics and prognosis.

Real-time tumor motion monitoring and PTV margin determination in lung SBRT treatment.

Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients.

Harmonization of proton treatment planning for head and neck cancer using pencil beam scanning: first report of the IPACS collaboration group.